The UK charity for Waldenstrom’s macroglobulinaemia – a rare type of blood cancer
Support Line: 0300 373 8500

Showing only trials that are South West England

A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
A first-in-human study to test the safety and efficacy of a new targeted treatment
Expected to end: 31/05/2025
Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies (ELM-1)
Understanding the best doses for Odronextamb in patients with a type of protein on their B-cells
Expected to end: 30/09/2025